It was a privilege for Lara Zibners, Co-Founder & Chairman, and I to meet with senior leadership of Brigham and Women’s Hospital in Boston led by Chief of the Division of Women’s Health Dr Kathryn Rexrode, Dr Raina Fichorova Chair in OBGYN / Vice Chair for Research, Sandra J. Butler, MPH Director of Design Impact, Dr Hadine Joffe, MD MSc and Dr Primavera Alessandra Spagnolo leading the Mary Horrigan Connors Center for Women’s Health and Gender Biology.

As one of the leading teaching and research hospitals in the world, we learned about the exciting progress and R&D efforts towards improving womens health. We were grateful for the opportunity to share info about our Callavid drug delivery technology; special thanks to Innovate UK Global Business Innovation Programme (GBIP) for facilitating this superb opportunity.